NEW YORK - (AP) AstraZeneca Plc said Tuesday it won a patent challenge brought against its blockbuster cholesterol drug Crestor by generic drug developers. The U.S. District Court in Delaware ruled that a key patent on the company's third best-selling drug is valid and that challenger Apotex could be held liable. . . . Full version available to lexis.com subscribers.